National Heart and Lung Institute, Imperial College London, Du Cane Road, London, W12 0NN, UK.
Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Genome Med. 2023 Oct 23;15(1):86. doi: 10.1186/s13073-023-01246-8.
As the availability of genomic testing grows, variant interpretation will increasingly be performed by genomic generalists, rather than domain-specific experts. Demand is rising for laboratories to accurately classify variants in inherited cardiac condition (ICC) genes, including secondary findings.
We analyse evidence for inheritance patterns, allelic requirement, disease mechanism and disease-relevant variant classes for 65 ClinGen-curated ICC gene-disease pairs. We present this information for the first time in a structured dataset, CardiacG2P, and assess application in genomic variant filtering.
For 36/65 gene-disease pairs, loss of function is not an established disease mechanism, and protein truncating variants are not known to be pathogenic. Using the CardiacG2P dataset as an initial variant filter allows for efficient variant prioritisation whilst maintaining a high sensitivity for retaining pathogenic variants compared with two other variant filtering approaches.
Access to evidence-based structured data representing disease mechanism and allelic requirement aids variant filtering and analysis and is a pre-requisite for scalable genomic testing.
随着基因组检测的可用性不断增加,变异解读将越来越由基因组通才而非特定领域的专家进行。实验室需要准确地对遗传性心脏疾病(ICC)基因中的变异进行分类,包括次要发现,因此需求不断增加。
我们分析了 65 个 ClinGen 编纂的 ICC 基因-疾病对的遗传模式、等位基因需求、疾病机制和与疾病相关的变异类别证据。我们首次在一个结构化数据集 CardiacG2P 中呈现这些信息,并评估其在基因组变异过滤中的应用。
对于 36/65 个基因-疾病对,功能丧失不是既定的疾病机制,且蛋白截断变异未知为致病性。与其他两种变异过滤方法相比,使用 CardiacG2P 数据集作为初始变异过滤器可以在保持高致病性变异保留灵敏度的同时,实现高效的变异优先级排序。
获得代表疾病机制和等位基因需求的基于证据的结构化数据有助于变异过滤和分析,是可扩展基因组测试的前提条件。